NCT07274969 is a clinical trial in Preterm Neonates, sponsored by Assiut University.

Who is sponsoring NCT07274969?

NCT07274969 is sponsored by Assiut University.

What condition does NCT07274969 study?

NCT07274969 studies Preterm Neonates, Apnea of Prematurity.

Is NCT07274969 still recruiting?

NCT07274969 is currently not yet recruiting. Last updated 10 December 2025.

Last reviewed 2025-12-10 · How we verify

NCT07274969

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU

Not yet recruiting Last updated 10 December 2025

What this trial tests

trial in Preterm Neonates in 40 participants. Not yet recruiting.

Timeline

30 June 2026

Primary endpoint
30 August 2027

30 December 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	40
Start date	30 June 2026
Primary completion	30 August 2027
Estimated completion	30 December 2027

Conditions studied

Preterm Neonates — all drugs for Preterm Neonates →
Apnea of Prematurity — all drugs for Apnea of Prematurity →

Sponsor

Assiut University

Who can join

Under 37 Weeks, any sex, with Preterm Neonates or Apnea of Prematurity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preterm neonates younger than 37 weeks gestational age receiving caffeine therapy for apnea of prematurity in a NICU setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Preterm Neonates

Currently open trials in the same condition.

NCT07154134 — Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07274969 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 10 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07274969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing